Teladoc Health, Inc. (0LDR.L)
USD 7.3
(3.11%)
USD 7.3
(3.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 468.6 Million USD | -28.47% |
| 2022 | 655.14 Million USD | 75.19% |
| 2021 | 373.96 Million USD | -48.91% |
| 2020 | 731.97 Million USD | 1595.37% |
| 2019 | -48.94 Million USD | -425.99% |
| 2018 | -9.3 Million USD | -105.66% |
| 2017 | 164.55 Million USD | 3043.18% |
| 2016 | -5.59 Million USD | 80.44% |
| 2015 | -28.58 Million USD | -40.09% |
| 2014 | -20.4 Million USD | -9525.94% |
| 2013 | -212 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 334.3 Million USD | -19.1% |
| 2024 Q1 | 492.32 Million USD | 5.06% |
| 2024 Q2 | 426.45 Million USD | -13.38% |
| 2023 Q3 | 541.65 Million USD | -11.94% |
| 2023 Q4 | 468.6 Million USD | -13.49% |
| 2023 FY | 468.6 Million USD | -28.47% |
| 2023 Q1 | 683.48 Million USD | 4.32% |
| 2023 Q2 | 615.09 Million USD | -10.01% |
| 2022 Q2 | 696.72 Million USD | -5.4% |
| 2022 Q1 | 736.49 Million USD | 96.94% |
| 2022 Q4 | 655.14 Million USD | -3.07% |
| 2022 FY | 655.14 Million USD | 75.19% |
| 2022 Q3 | 675.89 Million USD | -2.99% |
| 2021 Q4 | 373.96 Million USD | -13.09% |
| 2021 Q2 | 453.8 Million USD | -32.57% |
| 2021 Q3 | 430.27 Million USD | -5.19% |
| 2021 FY | 373.96 Million USD | -48.91% |
| 2021 Q1 | 673.01 Million USD | -8.05% |
| 2020 Q4 | 731.97 Million USD | 459.71% |
| 2020 FY | 731.97 Million USD | 1595.37% |
| 2020 Q3 | -203.48 Million USD | 37.76% |
| 2020 Q2 | -326.96 Million USD | -1183.76% |
| 2020 Q1 | -25.46 Million USD | 47.97% |
| 2019 Q3 | -10.45 Million USD | -156.52% |
| 2019 Q1 | 15.27 Million USD | 264.09% |
| 2019 Q2 | 18.5 Million USD | 21.17% |
| 2019 FY | -48.94 Million USD | -425.99% |
| 2019 Q4 | -48.94 Million USD | -368.1% |
| 2018 Q2 | 296.95 Million USD | 104.44% |
| 2018 Q3 | -48.9 Million USD | -116.47% |
| 2018 FY | -9.3 Million USD | -105.66% |
| 2018 Q4 | -9.3 Million USD | 80.97% |
| 2018 Q1 | 145.25 Million USD | -11.73% |
| 2017 Q2 | -165.38 Million USD | -69.61% |
| 2017 Q1 | -97.51 Million USD | -1644.12% |
| 2017 FY | 164.55 Million USD | 3043.18% |
| 2017 Q4 | 164.55 Million USD | -42.91% |
| 2017 Q3 | 288.21 Million USD | 274.26% |
| 2016 Q1 | -23.98 Million USD | 16.1% |
| 2016 Q2 | -24.39 Million USD | -1.7% |
| 2016 FY | -5.59 Million USD | 80.44% |
| 2016 Q4 | -5.59 Million USD | -1379.41% |
| 2016 Q3 | 437 Thousand USD | 101.79% |
| 2015 Q4 | -28.58 Million USD | -6.08% |
| 2015 Q3 | -26.95 Million USD | -256.37% |
| 2015 Q2 | 17.23 Million USD | 386.68% |
| 2015 Q1 | -6.01 Million USD | 70.54% |
| 2015 FY | -28.58 Million USD | -40.09% |
| 2014 Q4 | -20.4 Million USD | 0.0% |
| 2014 FY | -20.4 Million USD | -9525.94% |
| 2014 Q1 | 3.21 Million USD | 0.0% |
| 2013 FY | -212 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 720.361% |
| Accuray Incorporated | 103.58 Million USD | -352.38% |
| Align Technology, Inc. | -840.47 Million USD | 155.755% |
| Elevance Health Inc. | 18.59 Billion USD | 97.48% |
| AxoGen, Inc. | 32.26 Million USD | -1352.309% |
| Boston Scientific Corporation | 8.23 Billion USD | 94.308% |
| CVS Health Corporation | 71.18 Billion USD | 99.342% |
| Cardinal Health, Inc. | 476 Million USD | 1.554% |
| Centene Corporation | 506 Million USD | 7.391% |
| DaVita Inc. | 10.65 Billion USD | 95.601% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 98.855% |
| Hologic, Inc. | 374.4 Million USD | -25.161% |
| Humana Inc. | 5.51 Billion USD | 91.509% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 5.131% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 91.35% |
| Masimo Corporation | 804 Million USD | 41.716% |
| McKesson Corporation | 889 Million USD | 47.289% |
| Patterson Companies, Inc. | 648.47 Million USD | 27.738% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 89.994% |
| ResMed Inc. | 635.57 Million USD | 26.271% |
| Henry Schein, Inc. | 2.57 Billion USD | 81.766% |
| Universal Health Services, Inc. | 5.24 Billion USD | 91.069% |
| Veeva Systems Inc. | -647.71 Million USD | 172.347% |
| Baxter International Inc. | 11.16 Billion USD | 95.803% |
| Becton, Dickinson and Company | 14.46 Billion USD | 96.76% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 117.615% |
| Danaher Corporation | 13.49 Billion USD | 96.527% |
| Stryker Corporation | 10.02 Billion USD | 95.325% |
| Medtronic plc | 23.67 Billion USD | 98.021% |